longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

RxSight

RXST

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -4.19, above the reasonable range, cheaper than 1.53% of the time in the past 1 years, and the industry ranks 31/45, the industry Median -0.41.

-4.19xP/E
$4.73Stock price
$-1.13Earnings per share
-4.19xP/E
Stock price$4.73Earnings per share$-1.13

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-7.77x
Typical range
-11.16x–-4.99x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
017345168

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BLCOUSBausch + Lomb
-35.09x94.03%$6.00B
MMEDUSMiniMed
-18.31x146.72%$5.75B
NEOGUSNeogen
-377.04x316.68%$2.98B
ESTAUSEstablishment Labs
-50.25x30.16%$1.95B
XRAYUSDentsply Sirona
-3.48x113.34%$1.90B
KIDSUSOrthopediatrics
-14.88x27.74%$591.13M
CERSUSCerus
-77.54x56.25%$525.98M
SMTIUSSanara Medtech
-10.07x104.59%$322.50M
OSURUSOraSure Tech
-5.52x29.79%$271.05M
RXSTUSRxSight
-4.19x0.58%$196.74M
SKYAUSSkyAI
-0.20x--$81.31M
TELAUSTela Bio
-1.38x17.67%$57.02M
ZTEKFUSZENTEK LTD
-7.44x--$55.82M
XTNTUSXtant Med
-4.75x477.77%$52.87M
RMTIUSRockwell Medical
-6.59x32.67%$34.54M
NSPRUSInspireMD
-0.62x--$32.54M
RVPUSRetractable Tech
-5.68x--$20.45M
CUPRUSCuprina
-3.69x--$13.31M
LUCYUSInnovative Eyewear
-1.04x--$8.01M
AIDXUS20/20 Biolabs
-0.76x44.74%$5.40M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.